The role of pharmacokinetics in veterinary drug residues
Peter Lees1, Pierre-Louis Toutain
1The Royal Veterinary College, Hatfield, Herts, UK. PLees@rvc.ac.uk
Abstract:
This review provides a summary of those pharmacokinetic properties of veterinary drugs relevant to marker residues, marker tissues, and residue depletion rates. The scientific literature in this field is very extensive and there is also a wealth of data available on the websites of various regulatory jurisdictions. Therefore, this review is limited to selected examples, cited to illustrate general principles. The areas considered are: (1) the relationship of dose to plasma concentration through the pharmacokinetic properties, area under plasma concentration-time curve, bioavailability, and clearance; (2) the critical dependence of drug pharmacokinetics and residue depletion on product formulation; (3) disease state and population pharmacokinetics; and (4) the requirement for residue depletion studies for generic products shown to be bioequivalent to pioneer products.
Related Concept Videos
Pharmacokinetics: Overview
Toxicokinetics: Overview
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Pharmacogenetics of Drug Metabolism: Overview

